TMates logo

TMates Review

Best for: nationwide compounded GLP-1 availability including Puerto Rico

TMates is a Miami-based telehealth platform offering compounded semaglutide ($199/mo) and tirzepatide ($297/mo) across all 50 states plus Puerto Rico, operating on a messaging-first model with independent licensed prescribers and third-party compounding pharmacies.

By Eli Marsden · Founding Editor
Editorially reviewed (not clinically reviewed) · How we verify contentLast reviewed
6.3
★★★☆☆3.2
CompoundedSemaglutideTirzepatideAll 50 States
$249/mo
Same price at every dose

What the monthly price covers

Medication

Included

Provider visits

Included

Shipping

Included

Lab work

Not disclosed

Coaching

Included

See plans →

No insurance neededVetted by our editors

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

The Bottom Line

TMates is a solid telehealth option with balanced features and pricing.

Score: 6.3/10Best for: nationwide compounded GLP-1 availability including Puerto RicoFrom: $249/mo
TMates logo
3.2 / 5
Our editorial rating
Visit TMates

from $249/mo · no insurance needed

TMates at a glance

Type
GLP-1 telehealth provider
Medications
Semaglutide, Tirzepatide
Starting price
$249/mo (1-month plan; drops to $217/mo (3mo), $175/mo (6mo), $158/mo (12mo); injectable or oral, same price all doses)
Pricing model
Flat — dose increases don't raise the monthly price
What's included
Medication · Consult · Shipping · Coaching
Availability
All 50 states
FDA status
No FDA warning letter on record

How we scored TMates

Each dimension is scored algorithmically from TMates’s real pricing, drugs offered, verification status, and disclosed inclusions — using the same six-dimension framework we apply to every provider.

Value25%

5.4/10

At $249/mo, TMates runs about 46% above the $170 median for GLP-1 providers. Pricing is flat across doses, so there is no escalation markup as you titrate up.

Effectiveness25%

6.9/10

TMates offers both semaglutide and tirzepatide — the two GLP-1 molecules with the strongest published weight-loss trial outcomes.

User Experience15%

5.9/10

Online intake and platform experience — consult included in the price; 4 platform features disclosed.

Trust & Safety15%

6.8/10

Core details confirmed by our editors; no FDA warning letters on file; dispenses through an accredited compounding pharmacy (last checked 2026-06-06).

Accessibility10%

7.1/10

TMates treats patients in all 50 states.

Support10%

6.0/10

Coaching/dietitian access included.

How we verified this TMates review

Last checked 2026-06-06
  • Confirmed current pricing across 2 dose/plan tiers
  • Confirmed availability in all 50 states
  • Confirmed what the monthly price does and doesn't include
  • Checked the FDA warning-letter database for enforcement actions
  • Walked the public intake/checkout flow on the provider's site

Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records — see the sources below. Editorial confidence in this data: medium.

GLP-1 medications TMates offers

Tap any medication to read our plain-English guide — how it works, dosing, side effects, and what the trials found.

Pricing

Semaglutide 1-month plan (same price all doses)Compounded
$249/mo
semaglutide

1-month plan; drops to $217/mo (3mo), $175/mo (6mo), $158/mo (12mo); injectable or oral, same price all doses

Tirzepatide 1-month plan (same price all doses)Compounded
$297/mo
tirzepatide

1-month plan; drops to $267/mo (3mo), $217/mo (6mo), $167/mo (12mo); injectable or oral, same price all doses

Ready to get started?

Plans and promotions change often — check TMates's current pricing and active discounts before you decide.

See TMates pricing →

What we like

  • All-inclusive monthly price covers medication, consults, nutrition coaching, and 24/7 support — no separate membership fee
  • Available in all 50 states plus Puerto Rico and other US territories
  • Both compounded semaglutide and tirzepatide offered
  • Fast stated turnaround — 2–3 days from intake to delivery

Watch-outs

  • No third-party pharmacy accreditation (no LegitScript, PCAB, ACHC, or NABP)
  • BBB rating of B+ (not accredited) with complaints centered on billing and cancellation
  • Trustpilot reports of partial refunds and difficulty reaching support
  • Compounded only — no FDA-approved Ozempic, Wegovy, Zepbound, or Mounjaro
  • Pharmacy partners not named; routes medical and dispensing to third parties
  • Also sells testosterone and other wellness products — not GLP-1-focused
  • Lowest per-month prices require prepaying for 6- or 12-month plans ($1,050-$1,999 upfront)

TMates: the widest reach in compounded GLP-1, with a real catch on trust

TMates is a Miami-based telehealth platform that has built its whole pitch around one thing most competitors can't match: it ships compounded semaglutide and tirzepatide to all 50 states plus Puerto Rico and other US territories. If you live somewhere that most GLP-1 startups quietly skip, TMates is genuinely worth a look. But the same record that shows that nationwide footprint also shows no pharmacy accreditation and a pattern of billing complaints, so this is a provider you choose with your eyes open.

How TMates actually structures its pricing

TMates uses a flat, all-inclusive monthly rate — the headline $249 a month for semaglutide covers the medication, your telemedicine visit, nutrition coaching, and 24/7 support, with free shipping and no separate membership fee stacked on top. Crucially, the price is the same across every dose, so you won't get surprised by a bill that climbs as you titrate up. Tirzepatide sits higher, at its own flat monthly rate.

The lever that actually moves your cost isn't the dose — it's how far ahead you prepay. The advertised low numbers (down toward the category-low $170 range) only kick in if you commit to a 6- or 12-month plan, which means paying four figures up front — roughly a thousand dollars for a six-month semaglutide block, or close to two thousand for a full year. The one-month plan is the most expensive way to buy, and the least risky if you're not yet sure the medication or the company suits you.

  • Injectable or oral, same price — TMates offers both formats of each drug at the identical rate, which is unusual; oral compounds normally cost more.
  • No teaser rate — TMates doesn't dangle a flashy first-month promo. The price you see is the price you pay, which is more honest than some rivals but means no cheap way to trial it.
  • Discounts are commitment-based — the savings come from prepaying 3, 6, or 12 months, not from coupons.

The medications: compounded only, dispensed by partners it doesn't name

Be clear on what you're buying. TMates sells compounded semaglutide and tirzepatide only — there is no FDA-approved Ozempic, Wegovy, Zepbound, or Mounjaro here. Compounded drugs are mixed by a pharmacy rather than manufactured and FDA-approved as a finished product, which is how the price stays low, but it also means the formulation isn't the brand you'd get at a retail pharmacy. If brand-name medication matters to you, TMates is the wrong fit.

TMates is also explicit, in its own words, that it is a coordinator rather than a clinic or pharmacy: it 'does not practice medicine or any other licensed profession.' Independent licensed providers handle prescribing, and partner pharmacies do the dispensing. Those partner pharmacies are not named in any of the public material we verified — a meaningful gap, because you can't independently check the credentials of whoever is actually compounding your medication.

What genuinely sets TMates apart

Two things are real differentiators. First is the territory coverage — the all-50-states-plus-Puerto-Rico reach is verified and rare, and for patients in underserved areas it can be the deciding factor. Second is the stated speed: TMates advertises a 2–3 day turnaround from intake to delivery, which is fast for a mail-order compounded medication. The messaging-first model (you handle most of the process over chat rather than scheduled video) suits people who want a low-friction, no-phone-tag experience.

Where TMates falls short — the honest drawbacks

The cons here aren't trivial. TMates carries no third-party pharmacy accreditation — no LegitScript, PCAB, ACHC, or NABP seal on file. Its Better Business Bureau profile (under the legal entity 'Tmates / Teammates,' principal Sergio Padron) shows a B+ rating but is not BBB accredited, with complaints clustering around billing and cancellation. Trustpilot reviews echo that, citing partial refunds and trouble reaching support. Combine prepaid annual plans with reports of cancellation friction and you have a real reason to start on a shorter plan before committing money you'd struggle to get back.

It's also worth knowing TMates isn't GLP-1-focused — it sells testosterone and other wellness products alongside weight-loss medication, so it reads more like a general telehealth storefront than a dedicated obesity-medicine practice.

Who should choose TMates, and who should skip it

  • Choose it if: you live in a territory most providers don't serve (Puerto Rico especially), you want one flat all-inclusive price, and you're comfortable with compounded medication and a fast messaging-based process.
  • Skip it if: you want brand-name GLP-1s, you need the reassurance of a named, accredited pharmacy, or you're nervous about prepaying a long plan to a company with active billing and cancellation complaints.

Trust and safety: a medium-confidence verdict

On the positive side, no FDA warning letters were found for TMates in the FDA database as of our verification, and the company doesn't appear in the February 2026 mass-enforcement list. That's a genuine point in its favor. But the missing accreditation, the unnamed pharmacy partners, and the documented complaint pattern are why our scoring methodology lands TMates at medium confidence rather than high. The legal entity, Miami registration, and principal are all verifiable — the question marks are about oversight transparency, not whether the company is real.

Bottom line

TMates earns its place as the go-to for nationwide and territory-wide compounded GLP-1 access, with an honest flat price and fast delivery. But it asks for trust it hasn't fully backed with accreditation, and the billing complaints are real. The smart way to use TMates is to start on a one-month plan at $249, confirm the medication and the support live up to the pitch, and only then decide whether the deeper-discount annual commitment is worth the upfront risk.

Shopping around? Enhance MD ($212/month) and Direct Meds ($249/month) are the nearest alternatives to TMates in our rankings.

Ready to start with TMates?

Starting at $249/month. See current pricing and start your free consultation.

TMates might not be your best fit if…

We rank editorially, so here’s where a different provider we track may serve you better.

  • If you want brand-name Ozempic, Wegovy, Mounjaro or Zepbound, consider Gala.
  • If the lowest possible monthly price is your top priority, consider Telos Rx (from $49/mo).

Alternatives to TMates

8.6/ 10
Verified partner

Enhance MD

Best for: lab-monitored compounded GLP-1 with mandatory video visit

★★★★4.3

Editorial score · methodology

$49/mo
CompoundedSemaglutideTirzepatide
Get StartedRead full Enhance MD review →
8.5/ 10
Verified partner

Embody

Best for: lowest first-month entry pricing on compounded GLP-1s

★★★★4.3

Editorial score · methodology

$99/mo
CompoundedSemaglutideTirzepatide
Get StartedRead full Embody review →
8.5/ 10
Verified partner

TrimRx

Best for: best overall value

★★★★4.3

Editorial score · methodology

$179/mo
CompoundedSemaglutide
Get StartedRead full TrimRx review →

Frequently Asked Questions

Key terms, explained

New to GLP-1s? Tap any term for a quick, plain-English definition.

Sources

The primary regulatory filings and peer-reviewed studies cited throughout this TMates review:

Sources & methodology — as of July 2026
  1. 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)WeightLossRankings.org.
  2. 2.FDA — Compounding and the 503A Pharmacy FrameworkU.S. Food & Drug Administration.
  3. 3.FDA — Drug Shortages Database (current shortage listings)U.S. Food & Drug Administration.
  4. 4.PCAB — Pharmacy Compounding Accreditation Board StandardsAccreditation Commission for Health Care (ACHC) / PCAB.
  5. 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)Kaiser Family Foundation.
  6. 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)New England Journal of Medicine.PMID: 33567185.
  7. 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDAU.S. Food & Drug Administration.
  8. 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDAU.S. Food & Drug Administration.
  9. 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)New England Journal of Medicine.PMID: 35658024.
  10. 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDAU.S. Food & Drug Administration.
  11. 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDAU.S. Food & Drug Administration.
  12. 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)New England Journal of Medicine.PMID: 40334173.

Ready to start with TMates?

Starting at $249/month. See current pricing and start your free consultation.